No price history available.
Key financial summary
Financials in THB| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | THBm | 3,268 | 3,444 | 4,566 | 6,053 | 6,775 | 5,253 | N/A | N/A |
| Operating profit | THBm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net profit | THBm | 380 | 411 | 653 | 1,074 | 1,253 | 776 | N/A | N/A |
| EPS reported | THB | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating cashflow per share | THB | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Capex per share | THB | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF per share | THB | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Free cash flow | THBm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt | THBm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value equity | THBm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value per share | THB | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Number of shares | m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| DPS (TTM paid) | THB | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Financial summary
Financials in THB| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/B LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/S LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/FCF LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/EBITDA LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/Sales LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Earnings Yield LTM | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Quality | |||||||||
| ROE | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| ROIC | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Sales | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Growth and momentum | |||||||||
| EPS Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Sales Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Income Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating Profit Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend and capital structure | |||||||||
| Dividend Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Payout Ratio | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Debt | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Debt/EBITDA | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EBIT/Net interest | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/market cap | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/Equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross debt/equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
Company overview
Sappe Public Company Limited, together with its subsidiaries, manufactures and globally distributes a diverse range of healthy food and beverage products, serving both the Thai domestic market and international customers. The company's operations are organized into two primary segments: Health Drinking Products and Coconut Products. Within its health beverage portfolio, Sappe offers zero-sugar drinks like Sappe Beauti Drink, vitamin-infused fruit water known as B'lue, instant coffee solutions such as Preaw Coffee and SlimFit Coffee, powdered chlorophyll under the Preaw Chlorophyll brand, and Maxtive Coffee, a specialized blend for men. Its coconut and fruit juice offerings include Sappe Aloe Vera (fruit juice with aloe vera in various flavors), Mogu Mogu (the original fruit juice containing coconut jelly), and fragrant coconut water under the All Coco brand. Additionally, Sappe markets a variety of snacks and desserts: health and beauty jellies like Sappe Beauti Jelly, ZeaMax grilled fish snacks, Maxtive energy jellies, DeNosh organic soy puddings in jelly format, Gumi Gumi Jelly (a fruit jelly snack with carrageenan and konjac), Preaw Pudding's ready-to-eat konjac puddings, and All Coco Pudding desserts. Previously known as Sapanan General Food Company Limited, the company officially changed its name to Sappe Public Company Limited in September 2013. Established in 1973, Sappe Public Company Limited is headquartered in Bangkok, Thailand.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Sappe Public Company Limited (SAPPE.BK)
No price history available.
Based on consensus from external analysts. Not Kvantra's opinion.
Sappe Public Company Limited, together with its subsidiaries, manufactures and globally distributes a diverse range of healthy food and beverage products, serving both the Thai domestic market and international customers. The company's operations are organized into two primary segments: Health Drinking Products and Coconut Products. Within its health beverage portfolio, Sappe offers zero-sugar drinks like Sappe Beauti Drink, vitamin-infused fruit water known as B'lue, instant coffee solutions such as Preaw Coffee and SlimFit Coffee, powdered chlorophyll under the Preaw Chlorophyll brand, and Maxtive Coffee, a specialized blend for men. Its coconut and fruit juice offerings include Sappe Aloe Vera (fruit juice with aloe vera in various flavors), Mogu Mogu (the original fruit juice containing coconut jelly), and fragrant coconut water under the All Coco brand. Additionally, Sappe markets a variety of snacks and desserts: health and beauty jellies like Sappe Beauti Jelly, ZeaMax grilled fish snacks, Maxtive energy jellies, DeNosh organic soy puddings in jelly format, Gumi Gumi Jelly (a fruit jelly snack with carrageenan and konjac), Preaw Pudding's ready-to-eat konjac puddings, and All Coco Pudding desserts. Previously known as Sapanan General Food Company Limited, the company officially changed its name to Sappe Public Company Limited in September 2013. Established in 1973, Sappe Public Company Limited is headquartered in Bangkok, Thailand.
